ArticleOncoimmunology2021

TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients.

Jana Rakova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.